AHEAD Intelligence Co., Ltd is the parent company of AHEAD Medicine Corporation.

AHEAD Medicine is one of the 2020 Hello Tomorrow Deep Tech Pioneers and now among Berkeley SkyDeck Spring 2020 cohorts. https://skyportal.berkeley.edu/taipei/spring-2020-cohort-founders/ahead #BerkeleySkyDeck

AHEAD focuses on the development and application of AI enabled diagnostic and disease assessment tools to blood cancer treatment. We have developed leukemia cell detection models which allow physicians to identify abnormal cases promptly and avoid delays in clinical decisions such as whether to proceed with a bone marrow transplant or not. Our vision is to enable AI aided clinical decision making in the blood cancer treatment for every physician and to identify, optimize treatment strategies with ease. To know more about our progress, check our website or follow up on Twitter and Linkedin http://aheadmedicine.com https://twitter.com/AHEAD_Taiwan https://www.linkedin.com/company/aheadmedicine/ 收回

- Develop diagnostic and outcome prediction algorithms for hematological malignancies through artificial intelligence. - Data processing and statistical analysis with R programming. - Protocol and manuscript writing. Exhibition: 2019 CES (AHEAD is chosen as part of Taiwan Tech Arena Pavillion) http://taiwanarena.tech/announcement-ces-2019-taiwan-tech-arena-taiwan-pavilion-selection-result/ 2018 Taiwan Future Tech http://www.futuretech.org.tw/tech1_n.php?n=c75b6f114c23a4d7ea11331e7c00e73c&s=0 Publication: "Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome", EBioMedicine, 2018, https://doi.org/10.1016/j.ebiom.2018.10.042 Abstract #EHA-1912, European Hematology Association Annual Congress 2018 Abstract #1403, #2042, #3980, American Society of Hematology Annual Meeting 2017 收回

Marketing strategy planning and implementation for Colorectal cancer, GIST and prostate cancer products (Stivarga and Xofigo)

Responsible for marketing strategy and event planning, implement and monitoring for oncology/hematology products.

Responsible for pre-launch projects for narcotic and hematology/oncology products. Support cross functional team for market access, regulatory affairs, marketing, and key account management.

Narcotic product listing in North Taiwan. Support pre-launch projects and brand plan development for narcotics, hematology/oncology products.

Responsible for narcotic products. Support pre-launch projects and business brand plan for narcotic products.

Sales promotion and event planning for narcotic products in Hong Kong private sector

Promote oncology product lines in medical centers and key regional hospitals in North Taiwan, including VGH-TP, MMH, WFH, TMUH and Hsin Chu area.

I worked under Dr. Yi-Ching Wang's lab on Lung cancer related research. My main tasks included tissue culture, molecular biology, biochemistry, new technique training ,and administrative support etc